{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"In the Company of Mavericks ","title":"Peter Keeling of Diaceutics ","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/115b61bb\"></iframe>","width":"100%","height":180,"duration":3080,"description":"This episode is made possible by Progressive Equity Research Ltd. A great conversation with two Irishmen with deep domain knowledge in commercialising modern pharmaceutical products. This is a journey into the world of precision medicine and diagnostics. Padraic Dempsey, formerly CCO at Uniphar, joins me for a fascinating conversation with Peter Keeling, the founder and CEO of Diaceutics PLC. Diaceutics' data platform DXRX sits at the intersection of life science and data science as a diagnostic commercialisation tool used by the World's largest pharmaceutical and biotech companies helping patients find the right therapy. It might not sound like a big deal, but as therapies become more targeted, it is much more difficult for the right drugs to find the right patients at the right time. ","thumbnail_url":"https://img.transistorcdn.com/9KtnHRxXk3NfZD5AuEQJNibHUq-wWk5XYkUv5CvBNrg/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS81MWMw/ODIxNTVlMzkwMzBk/ODIyN2IwOTExMzYy/N2VhNy5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}